## EXPD: Expeditors International of Washington, Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 2.9% below STRENGTH zone (4.0-10.0%); PEG 5.28 fails VALUE criteria (<1.0); RSI 72 overbought. Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.5% MRS), overbought RSI (72).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($141.71)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 5, Bearish: 0)

**1. UPS vs. EXPD: Which Dividend-Paying Stock Reigns Supreme Currently?**
- Source: TradingView | 20251202T172129 | Bullish | Relevance: 100%
- This article compares UPS and Expeditors International (EXPD), two dividend-paying transportation stocks, during a period of economic uncertainty. While both increased dividends, UPS's dividend sustainability is questioned due to its high payout ratio and declining free cash flow, unlike EXPD. EXPD is highlighted as a more attractive investment due to stronger price performance, improving airfreight landscape, and better earnings estimates despite its higher valuation.

**2. Airfreight and AI Infrastructure Boost Expeditors' (EXPD) Outlook, According to BofA**
- Source: Finviz | 20251202T080700 | Somewhat-Bullish | Relevance: 100%
- BofA raised its price target on Expeditors International (EXPD) to $150 from $142, maintaining a Neutral rating, after a conference call with the company's CEO and CFO. The firm increased its FY26 EPS forecast by 3% to $6.50, citing stronger demand in Customs and Airfreight, especially due to growing airfreight tonnage on exports from North and South Asia and significant investments by technology customers in AI infrastructure. Expeditors also repurchased $212 million of common stock and returned $725 million to shareholders year-to-date through buybacks and dividends.

**3. 6 Reasons Why You Should Add Expeditors Stock to Your Portfolio**
- Source: MSN | 20251201T033611 | Bullish | Relevance: 100%
- This article highlights six reasons to consider adding Expeditors International of Washington (EXPD) stock to an investment portfolio. Key factors include its strong Zacks Rank #1 (Strong Buy), impressive earnings outperformance, consistent dividend growth, global logistics market expansion, effective capital management through share buybacks, and its position as a leading non-asset-based logistics provider. These points suggest EXPD offers a compelling investment opportunity due to its financial strength, market position, and shareholder returns.

**4. Expeditors International stock hits all-time high at 148.4 USD**
- Source: Investing.com India | 20251203T225400 | Bullish | Relevance: 100%
- Expeditors International's stock reached an all-time high of $148.4 USD, driven by strong demand for its logistics services, a share buyback program, and a consistent dividend yield. Despite appearing overvalued by InvestingPro analysis, recent strong Q3 earnings and favorable analyst upgrades from Goldman Sachs, Stifel, BofA Securities, and UBS indicate positive sentiment and continued financial strength for the company.

**5. Schroder Investment Management Group Increases Stock Holdings in Expeditors International of Washington, Inc. $EXPD**
- Source: MarketBeat | 20251203T123646 | Neutral | Relevance: 100%
- Schroder Investment Management Group significantly increased its stake in Expeditors International of Washington, Inc. (NASDAQ:EXPD) by 18.3% in Q2, acquiring an additional 42,237 shares to own a total of 273,554 shares valued at approximately $31.25 million. This move comes amidst mixed analyst ratings with a consensus "Hold," a $131.89 target price, and recent insider selling. The company also announced a $0.77 dividend payable in December.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 6, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-17 | UBS | $166 | $138 | +20% |
| 2025-11-06 | Stifel | $130 | $114 | +14% |
| 2025-11-05 | UBS | $138 | $120 | +15% |
| 2025-11-05 | JP Morgan | $134 | $116 | +16% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-17 | UBS | up | Buy |
| 2025-11-06 | Stifel | main | Hold |
| 2025-11-05 | UBS | main | Neutral |
| 2025-11-05 | JP Morgan | main | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 8 ($0.01M) |
| Sells | 2 ($0.93M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 12.5% (-0.9%)
- Blackrock Inc.: 9.2% (-10.1%)
- State Street Corpora: 5.8% (+5.1%)
- First Eagle Investme: 4.7% (+0.0%)
- LOOMIS SAYLES & CO L: 4.3% (+1.6%)

### Key Risks

1. Valuation stretched: PEG 5.3x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 6 raises (avg +15%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 5.28 signals overvaluation risk, limited margin of safety. Forward P/E 24.8x stretched relative to 2% growth. Quality metrics strong (ROE 36%, ROA 14%). Analyst sentiment positive (6 raises, avg +15%). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $20.7B |
| Beta | 1.14 |
| 52W Range | $100.47 - $155.04 |
| Short Interest | 4.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 5.28 |
| Forward P/E | 24.8 |
| Current P/E | 25.2 |
| YoY Growth | 1.5% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 6.4% to 2.9% (-3.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.1pp (needs >4.0% for momentum thesis). MRS_5 at 0.4% confirms short-term momentum alignment. AM_20 at 4.8% shows strong absolute momentum above own 20MA. Outperforming sector by 3.4pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). RSI overbought at 72, risk of mean reversion. OFD pattern: +SLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.89% (CS: 77) | Neutral |
| RSI_14 | 72.3 | Overbought |
| MACD Histogram | 0.08 | Bullish |
| vs SMA20 | 1.044x | Above |
| vs SMA50 | 1.148x | Above |
| vs SMA200 | 1.243x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $148.09
- **Stop Loss:** $141.71 (4.3% risk)
- **Target:** $154.47 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 148
- **Position Value:** $21,917.32
- **Portfolio %:** 21.92%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderately constructive conditions. Fed dovish pivot expectations from weak jobs data and declining VIX suggest improving risk appetite, though narrow breadth at 51% indicates selective participation. Focus on quality sectors benefiting from rate cut expectations.*

### Earnings

**Next:** 2026-02-24 (Est: $1.43)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.39 | $1.64 | +18.1% |
| 2025Q2 | $1.24 | $1.34 | +7.9% |
| 2025Q1 | $1.35 | $1.47 | +9.1% |
| 2024Q4 | $1.44 | $1.68 | +16.7% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*